terazosin , a new selective long-acting alpha1-adrenergic blocking agent , has been shown to be an effective once-daily antihypertensive agent in four of five randomized double-blind placebo-controlled studies of patients with mild to moderate hypertension .
C0076107
terazosin
C0020538
hypertension